Skip to main content

Table 3 Variables that achieved significance in the univariate comparisons between treatment groups

From: An examination of factors influencing the choice of therapy for patients with coronary artery disease

VARIABLES

Likelihood ratio

Exp (β)

Confidence interval

RATES/MEAN SCORES

 

Model change

df.

Sig.

Odds Ratio

Lower bound

Upper bound

Reference

Response

(a) PTCA from Medication

      

Medication

PTCA

   Increasing age

4.644

1

0.031

0.967

0.928

1.008

66.00

62.03

   Higher educational attainment

6.887

1

0.009

1.447

0.999

2.096

1.97

2.51

   Previous intervention

20.517

1

< 0.001

8.961

2.055

39.067

4

25

   Hypertension

4.505

1

0.034

0.482

0.197

1.178

36

24

   Family history: IHD

9.306

1

0.002

0.342

0.136

0.863

51

34

   LAD artery disease

21.166

1

< 0.001

2.328

1.392

3.893

1.56

2.31

   Angina frequency

11.204

1

0.001

2.351

1.182

4.677

1.80

2.18

   Angina functional limitations

11.079

1

0.001

1.651

1.102

2.474

1.29

1.93

   Dyspnoea functional limitations

5.851

1

0.016

1.444

0.968

2.153

1.21

1.67

(b) CABG from PTCA

      

PTCA

CABG

   Higher educational attainment

19.186

1

< 0.001

0.525

0.350

0.786

2.51

1.64

   Previous intervention

16.410

1

< 0.001

0.165

0.046

0.587

25

6

   Family history: IHD

7.251

1

0.007

2.523

1.028

6.192

34

51

   Family history: Neurological

5.400

1

0.020

0.194

0.025

1.527

9

2

   Cerebral events

5.505

1

0.019

0.127

0.008

2.065

7

1

   LAD artery disease

6.996

1

0.008

1.834

0.980

3.435

2.31

2.64

   Circumflex artery disease

22.489

1

< 0.001

2.058

1.352

3.132

1.39

2.30

   RCA disease

5.600

1

0.018

1.444

0.960

2.173

1.85

2.27

   Number of vessels diseased

12.709

1

< 0.001

2.546

1.221

5.310

2.37

2.77

   Ventricular disease

12.979

1

< 0.001

2.037

1.172

3.540

0.39

0.93

   SIP: Social behaviour

7.937

1

0.005

1.182

1.010

1.382

3.97

5.32

   SIP: Mobility range

35.312

1

< 0.001

1.608

1.254

2.062

1.15

3.52

(c) CABG from Medication

      

Medication

CABG

   Gender

6.612

1

0.010

0.306

0.088

1.062

18

7

   Hypercholesterolemia

6.892

1

0.009

0.410

0.169

0.994

45

31

   Hypertension

6.773

1

0.009

0.407

0.166

1.003

36

22

   Cerebral events

12.419

1

< 0.001

0.067

0.004

1.018

12

1

   LAD artery disease

54.350

1

< 0.001

5.396

2.553

11.407

1.56

2.64

   Circumflex artery disease

32.294

1

< 0.001

2.647

1.617

4.333

1.30

2.30

   RCA disease

7.800

1

0.005

1.599

1.024

2.495

1.80

2.27

   Number of vessels diseased

9.668

1

0.002

2.116

1.080

4.144

2.39

2.77

   Ventricular disease

7.173

1

0.007

1.737

0.998

3.023

0.56

0.93

   Angina frequency

5.824

1

0.016

1.710

0.949

3.080

1.80

2.11

   Angina functional limitations

15.130

1

< 0.001

1.660

1.168

2.358

1.29

2.15

   Dyspnoea functional limitations

7.619

1

0.006

1.450

1.015

2.072

1.21

1.79

   SIP: Social behaviour

7.714

1

0.005

1.175

1.008

1.371

3.96

5.32

   SIP: Mobility range

40.346

1

< 0.001

1.683

1.299

2.181

1.00

3.52

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us